STUDIES OF CYCLODEXTRIN INCLUSION COMPLEXES .2. MOLECULAR MODELING AND H-1-NMR EVIDENCE FOR THE SALBUTAMOL-BETA-CYCLODEXTRIN COMPLEX

被引:32
作者
MARQUES, HMC [1 ]
HADGRAFT, J [1 ]
KELLAWAY, IW [1 ]
PUGH, WJ [1 ]
机构
[1] UNIV WALES COLL CARDIFF,WELSH SCH PHARM,POB 13,CARDIFF CF1 3XF,WALES
关键词
Computer graphics; Inclusion complexation; Molecular ratio; NMR; !sup]1[!/sup]H-; Salbutamol; β-Cyclodextrin;
D O I
10.1016/0378-5173(90)90133-O
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
β-Cyclodextrin (β-CYD) has a hydrophobic cavity in which salbutamol may be clathrated. The ability of a guest molecule to penetrate the CYD host is determined by its size, stereochemistry and polarity. Intermolecular interactions such as the hydrophobic interaction, van der Waals forces, H bonding and other physical forces are involved in the inclusion complexation process. Proton-NMR was employed to assess the mode of inclusion of salbutamol within the β-CYD cavity. The technique is based on the shielding of the CYD and drug protons. If inclusion does occur, protons located within or near the CYD cavity should be strongly shielded. The spectra showed upfield shifts of the CYD protons in the presence of salbutamol and the salbutamol protons shifted downfield in the presence of β-CYD. The downfield shifts of the aromatic protons were greater than those of the aliphatic protons, suggesting that the aromatic ring of salbutamol interacts more strongly with the β-CYD. The interior protons of the CYD molecule were shielded as a result of the anisotropy of the guest aromatic moiety. The highest shifts of β-CYD protons occurred for a molar ratio of 1:1 (salbutamol:β-CYD) indicating the probable stoichiometry of the complex. Molecular graphical computation showed that the minimum van der Waals energy positioning of salbutamol relative to β-CYD occurs when the aromatic ring of salbutamol penetrates the cavity leaving the aliphatic chain externalised. © 1990.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 18 条
[1]  
Aboul-Enein H.Y., 1981, ANAL PROFILES DRUG S, V10, P665
[2]   THERMODYNAMICS OF CYCLOAMYLOSE-SUBSTRATE COMPLEXATION [J].
BERGERON, RJ ;
PILLOR, DM ;
GIBEILY, G ;
ROBERTS, WP .
BIOORGANIC CHEMISTRY, 1978, 7 (02) :263-271
[3]  
Demarco P. V, 1970, J CHEM SOC CHEM COMM, P2, DOI [DOI 10.1039/C29700000002, 10.1039/c29700000002, 10.1039/C29700000002]
[4]   PHASE SOLUBILITY ANALYSIS AND PMR STUDY OF COMPLEXING BEHAVIOR OF DINOPROSTONE WITH BETA-CYCLODEXTRIN IN WATER [J].
FRANK, SG ;
CHO, MJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1978, 67 (12) :1665-1668
[5]  
Higuchi T., 1965, PHASE SOLUBILITY TEC, V4, P117
[6]  
JONES SP, 1984, ACTA PHARM TECH, V30, P213
[7]  
MARQUES HMC, 1990, IN PRESS INT J PHARM, V63
[8]  
OTAGIRI M, 1975, CHEM PHARM BULL, V23, P188
[9]   ON CONFORMATION OF D-GLUCOPYRANOSE RING IN MALTOSE AND IN HIGHER POLYMERS OF D-GLUCOSE [J].
RAO, VSR ;
FOSTER, JF .
JOURNAL OF PHYSICAL CHEMISTRY, 1963, 67 (04) :951-&
[10]   CYCLODEXTRIN INCLUSION-COMPOUNDS IN RESEARCH AND INDUSTRY [J].
SAENGER, W .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 1980, 19 (05) :344-362